EndoStim Raises $6 Million

EndoStim Inc., a St Louis-based developer of minimally-invasive interventional therapies to treat gastrointestinal and urological neuro-muscular disorders, has raised $6 million in Series B funding. Santé Ventures led the round, and was joined by Prolog Ventures, Vectis Healthcare & Life Sciences Fund and individual angels.

PE HUB Community

Join the 12515 members of PE HUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget